Aripiprazole in the treatment of irritability associated with autistic disorder in paediatric patients: Profile report

CNS Drugs

Volumn 25, Issue 9, 2011, Pages 801-802

  Curran, Monique P ^a  

^a ADIS INTERNATIONAL LIMITED   (New Zealand)

Author keywords

Adis Profile Reports; Aripiprazole; Autistic disorder; Irritability

Indexed keywords

ARIPIPRAZOLE; PLACEBO;

AREA UNDER THE CURVE; ARTICLE; AUTISM; BEHAVIOR DISORDER; CHILD BEHAVIOR; CHILD BEHAVIOR CHECKLIST; CLINICAL GLOBAL IMPRESSION SCALE; DECREASED APPETITE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG CLEARANCE; DRUG EFFICACY; DRUG FEVER; DRUG MECHANISM; DRUG TOLERABILITY; EXTRAPYRAMIDAL SYNDROME; FATIGUE; HUMAN; HYPERSALIVATION; IRRITABILITY; LETHARGY; MAXIMUM PLASMA CONCENTRATION; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; SEDATION; SIDE EFFECT; SOMNOLENCE; TIME TO MAXIMUM PLASMA CONCENTRATION; TREATMENT OUTCOME; TREMOR; VOMITING; WEIGHT GAIN;

ADOLESCENT; AUTISTIC DISORDER; CHILD; DOUBLE-BLIND METHOD; HUMANS; IRRITABLE MOOD; PIPERAZINES; QUINOLONES; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 80052140394     PISSN: 11727047     EISSN: 11791934     Source Type: Journal    
DOI: 10.2165/11208280-000000000-00000     Document Type: Article

References (9)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed., text rev. Washington, DC: American Psychiatric Association, 2000
2. Curran MP. Aripiprazole: in the treatment of irritability associated with autistic disorder in pediatric patients. Pediatr Drugs 2011; 13 (3): 197-204
3. Bristol-Myers Squibb. Abilify®(aripiprazole) tablets: US prescribing information [online]. Available from URL: http://www.abilify.com/pds/pi.aspx [Accessed 2011 Jan 10]
4. Findling RL, Kauffman R, Sallee FR, et al. An open-label study of aripiprazole: pharmacokinetics, tolerability, and effectiveness in children and adolescents with conduct disorder. J Child Adolesc Psychopharmacol 2009; 19 (4): 431-9
5. Robb AS, Andersson C, Bellocchio EE, et al. Safety and tolerability of aripiprazole in the treatment of irritability associated with autistic disorder in pediatric subjects (6-17 years old): results from a pooled analysis of 2 studies. Prim Care Companion CNS Disord 2011; 13 (1). pii: PCC. 10m01088
6. Malone RP, Waheed A. The role of antipsychotics in the management of behavioural symptoms in children and adolescents with autism. Drugs 2009; 69 (5): 535-48
7. Owen R, Sikich L, Marcus RN, et al. Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder. Pediatrics 2009 Dec; 124 (6): 1533-40
8. Marcus RN, Owen R, Kamen L, et al. A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder. J Am Acad Child Adolesc Psychiatry 2009 Nov; 48 (11): 1110-9
9. Bristol-Myers Squibb. Final study report for study CN138180: a 52-week open-label multicenter study of the safety and tolerability of aripiprazole flexibly doses in the treatment of children and adolescents with austistic disorder [online]. Available from URL: http://www.clinicalstudyresults.org/ documents/companystudy-8998-2.pdf [Accessed 2011 Jan 9]